An artificial heart valve is a one-way valve implanted into a person's heart to replace a valve that is not functioning properly. Artificial heart valves can be separated into three broad classes: mechanical heart valves, bioprosthetic tissue valves and engineered tissue valves.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Artificial Heart Valve industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Market Segment by Product Application
Hospital
Clinic
Finally, the report provides detailed profile and data information analysis of leading company.
Edwards Lifesciences
Cryolife
Boston Scientific Corporation
Medtronic
Jenavalve Technology
St. Jude Medical
Colibri Heart Valve
Symetis
Livanova
TTK Healthcare Limited
Lepu Medical Technology
Autotissue Berlin GmbH
Braile Biom?dica
Micro Interventional
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Artificial Heart Valve consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Artificial Heart Valve market by identifying its various subsegments.
3.Focuses on the key global Artificial Heart Valve manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Artificial Heart Valve with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Artificial Heart Valve submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Artificial Heart Valve Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Artificial Heart Valve Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Artificial Heart Valve Segment by Type
2.1.1 Transcatheter Heart Valves
2.1.2 Tissue Heart Valves
2.1.3 Mechanical Heart Valves
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.3 Global Artificial Heart Valve Market Comparison by Regions (2017-2027)
2.3.1 Global Artificial Heart Valve Market Size (2017-2027)
2.3.2 North America Artificial Heart Valve Status and Prospect (2017-2027)
2.3.3 Europe Artificial Heart Valve Status and Prospect (2017-2027)
2.3.4 Asia-pacific Artificial Heart Valve Status and Prospect (2017-2027)
2.3.5 South America Artificial Heart Valve Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Artificial Heart Valve Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Artificial Heart Valve Industry Impact
2.5.1 Artificial Heart Valve Business Impact Assessment - Covid-19
2.5.2 Market Trends and Artificial Heart Valve Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Artificial Heart Valve Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Artificial Heart Valve Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Artificial Heart Valve Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Artificial Heart Valve Manufacturer Market Share
3.5 Top 10 Artificial Heart Valve Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Artificial Heart Valve Market
3.7 Key Manufacturers Artificial Heart Valve Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Artificial Heart Valve Industry Key Manufacturers
4.1 Edwards Lifesciences
4.1.1 Company Details
4.1.2 Edwards Lifesciences Artificial Heart Valve Product Introduction, Application and Specification
4.1.3 Edwards Lifesciences Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Edwards Lifesciences News
4.2 Cryolife
4.2.1 Company Details
4.2.2 Cryolife Artificial Heart Valve Product Introduction, Application and Specification
4.2.3 Cryolife Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Cryolife News
4.3 Boston Scientific Corporation
4.3.1 Company Details
4.3.2 Boston Scientific Corporation Artificial Heart Valve Product Introduction, Application and Specification
4.3.3 Boston Scientific Corporation Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Boston Scientific Corporation News
4.4 Medtronic
4.4.1 Company Details
4.4.2 Medtronic Artificial Heart Valve Product Introduction, Application and Specification
4.4.3 Medtronic Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Medtronic News
4.5 Jenavalve Technology
4.5.1 Company Details
4.5.2 Jenavalve Technology Artificial Heart Valve Product Introduction, Application and Specification
4.5.3 Jenavalve Technology Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Jenavalve Technology News
4.6 St. Jude Medical
4.6.1 Company Details
4.6.2 St. Jude Medical Artificial Heart Valve Product Introduction, Application and Specification
4.6.3 St. Jude Medical Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 St. Jude Medical News
4.7 Colibri Heart Valve
4.7.1 Company Details
4.7.2 Colibri Heart Valve Artificial Heart Valve Product Introduction, Application and Specification
4.7.3 Colibri Heart Valve Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Colibri Heart Valve News
4.8 Symetis
4.8.1 Company Details
4.8.2 Symetis Artificial Heart Valve Product Introduction, Application and Specification
4.8.3 Symetis Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Symetis News
4.9 Livanova
4.9.1 Company Details
4.9.2 Livanova Artificial Heart Valve Product Introduction, Application and Specification
4.9.3 Livanova Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Livanova News
4.10 TTK Healthcare Limited
4.10.1 Company Details
4.10.2 TTK Healthcare Limited Artificial Heart Valve Product Introduction, Application and Specification
4.10.3 TTK Healthcare Limited Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 TTK Healthcare Limited News
4.11 Lepu Medical Technology
4.11.1 Company Details
4.11.2 Lepu Medical Technology Artificial Heart Valve Product Introduction, Application and Specification
4.11.3 Lepu Medical Technology Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Lepu Medical Technology News
4.12 Autotissue Berlin GmbH
4.12.1 Company Details
4.12.2 Autotissue Berlin GmbH Artificial Heart Valve Product Introduction, Application and Specification
4.12.3 Autotissue Berlin GmbH Artificial Heart Valve Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Autotissue Berlin GmbH News
4.13 Braile Biom